SyncThink, a Boston-based applying VR and eye-tracking to assess ability to focus as an indicator of concussion damage, has launched the next generation of its FDA-cleared EYE-SYNC platform.
In a new study led by Children's Hospital of Philadelphia (CHOP), researchers found that novel eye-tracking metrics can help properly identify concussion-related vision disorders, a common phenomenon ...
The US Food and Drug Administration (FDA) has granted breakthrough designation for SyncThink's Eye-Sync technology, a virtual reality eye-tracking platform that provides objective measurements to aid ...
Philadelphia, July 30, 2025 – In a new study led by Children’s Hospital of Philadelphia (CHOP), researchers found that novel eye-tracking metrics can help properly identify concussion-related vision ...
Boston-based eye tracking company SyncThink has made major changes to its marketing materials since the FDA objected to its labeling in a warning letter. The letter is dated July 31st; MedCityNews ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
With the ever-growing popularity of women's soccer, attention to sports-related concussions is also a growing concern, as the act of heading the ball is thought to contribute to increased incidence of ...
In a new study led by Children's Hospital of Philadelphia (CHOP), researchers found that novel eye-tracking metrics can help properly identify concussion-related vision disorders, a common phenomenon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results